IP Library Granted Patent US 10,487,343
Granted Patent B2
US 10,487,343 · App. 15/645,880 · Granted Nov 26, 2019

Microorganisms and methods for the biosynthesis of butadiene

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,487,343
App. No.
15/645,880
Granted
Nov 26, 2019
Kind
B2
Abstract

The invention provides non-naturally occurring microbial organisms having a butadiene pathway. The invention additionally provides methods of using such organisms to produce butadiene.

Claims (45)

1. A non-naturally occurring microbial organism comprising a biosynthetic pathway for the production of crotyl alcohol wherein said biosynthetic pathway comprises at least one exogenous nucleic acid encoding at least one metabolic pathway enzyme expressed in a sufficient amount to produce crotyl alcohol, wherein said biosynthetic pathway comprises converting crotonyl-CoA to crotyl alcohol using one or more metabolic pathway enzymes, wherein said metabolic pathway enzymes are selected from the group consisting of:

(i) a crotonyl-CoA reductase converting crotonyl-CoA to crotonaldehyde, and a crotonaldehyde reductase converting crotonaldehyde to crotyl alcohol;

(ii) a crotonyl-CoA reductase converting crotonyl-CoA to crotyl alcohol; and

(iii) a crotonyl-CoA hydrolase, a crotonyl-CoA synthetase, or a crotonyl-CoA transferase converting crotonyl-CoA to crotonate, a crotonate reductase converting crotonate to crotonaldehyde, and a crotonaldehyde reductase converting crotonaldehyde to crotyl alcohol, and

wherein said biosynthetic pathway further comprises:

(i) converting acetyl-CoA to crotonyl-CoA using an acetyl-CoA:acetyl-CoA acyltransferase, an acetoacetyl-CoA reductase and a 3-hydroxybutyryl-CoA dehydratase;

(ii) converting glutaconyl-CoA to crotonyl-CoA using a glutaconyl-CoA decarboxylase;

(iii) converting glutaryl-CoA to crotonyl-CoA using a glutaryl-CoA dehydrogenase;

(iv) converting 3-aminobutyryl-CoA to crotonyl-CoA using an 3-aminobutyryl-CoA deaminase; or

(v) converting 4-hydroxybutyryl-CoA to crotonyl-CoA using a 4-hydroxybutyryl-CoA dehydratase.

2. The non-naturally occurring microbial organism of claim 1 , wherein said microbial organism comprises one exogenous nucleic acid encoding a metabolic pathway enzyme.

3. The non-naturally occurring microbial organism of claim 1 , wherein said biosynthetic pathway comprises a crotonyl-CoA reductase converting crotonyl-CoA to crotonaldehyde and a crotonaldehyde reductase converting crotonaldehyde to crotyl alcohol.

4. The non-naturally occurring microbial organism of claim 3 , wherein said biosynthetic pathway further comprises converting acetyl-CoA to crotonyl-CoA using an acetyl-CoA:acetyl-CoA acyltransferase, an acetoacetyl-CoA reductase and a 3-hydroxybutyryl-CoA dehydratase.

5. The non-naturally occurring microbial organism of claim 3 , wherein said biosynthetic pathway further comprises converting glutaconyl-CoA to crotonyl-CoA using a glutaconyl-CoA decarboxylase.

6. The non-naturally occurring microbial organism of claim 3 , wherein said biosynthetic pathway further comprises converting glutaryl-CoA to crotonyl-CoA using a glutaryl-CoA dehydrogenase.

7. The non-naturally occurring microbial organism of claim 3 , wherein said biosynthetic pathway further comprises converting 3-aminobutyryl-CoA to crotonyl-CoA using an 3-aminobutyryl-CoA deaminase.

8. The non-naturally occurring microbial organism of claim 3 , wherein said biosynthetic pathway further comprises converting 4-hydroxybutyryl-CoA to crotonyl-CoA using a 4-hydroxybutyryl-CoA dehydratase.

9. The non-naturally occurring microbial organism of claim 1 , wherein said biosynthetic pathway comprises a crotonyl-CoA reductase converting crotonaldehyde to crotyl alcohol.

10. The non-naturally occurring microbial organism of claim 9 , wherein said biosynthetic pathway further comprises converting acetyl-CoA to crotonyl-CoA using an acetyl-CoA:acetyl-CoA acyltransferase, an acetoacetyl-CoA reductase and a 3-hydroxybutyryl-CoA dehydratase.

11. The non-naturally occurring microbial organism of claim 9 , wherein said biosynthetic pathway further comprises converting glutaconyl-CoA to crotonyl-CoA using a glutaconyl-CoA decarboxylase.

12. The non-naturally occurring microbial organism of claim 9 , wherein said biosynthetic pathway further comprises converting glutaryl-CoA to crotonyl-CoA using a glutaryl-CoA dehydrogenase.

13. The non-naturally occurring microbial organism of claim 9 , wherein said biosynthetic pathway further comprises converting 3-aminobutyryl-CoA to crotonyl-CoA using an 3-aminobutyryl-CoA deaminase.

14. The non-naturally occurring microbial organism of claim 9 , wherein said biosynthetic pathway further comprises converting 4-hydroxybutyryl-CoA to crotonyl-CoA using a 4-hydroxybutyryl-CoA dehydratase.

15. The non-naturally occurring microbial organism of claim 1 , said biosynthetic pathway comprises a crotonyl-CoA hydrolase, crotonyl-CoA synthetase or crotonyl-CoA transferase converting crotonyl-CoA to crotonate, a crotonate reductase converting crotonate to crotonaldehyde, and crotonaldehyde reductase converting crotonaldehyde to crotyl alcohol.

16. The non-naturally occurring microbial organism of claim 15 , wherein said biosynthetic pathway further comprises converting acetyl-CoA to crotonyl-CoA using an acetyl-CoA:acetyl-CoA acyltransferase, an acetoacetyl-CoA reductase and a 3-hydroxybutyryl-CoA dehydratase.

17. The non-naturally occurring microbial organism of claim 15 , wherein said biosynthetic pathway further comprises converting glutaconyl-CoA to crotonyl-CoA using a glutaconyl-CoA decarboxylase.

18. The non-naturally occurring microbial organism of claim 15 , wherein said biosynthetic pathway further comprises converting glutaryl-CoA to crotonyl-CoA using a glutaryl-CoA dehydrogenase.

19. The non-naturally occurring microbial organism of claim 15 , wherein said biosynthetic pathway further comprises converting 3-aminobutyryl-CoA to crotonyl-CoA using an 3-aminobutyryl-CoA deaminase.

20. The non-naturally occurring microbial organism of claim 15 , wherein said biosynthetic pathway further comprises converting 4-hydroxybutyryl-CoA to crotonyl-CoA using a 4-hydroxybutyryl-CoA dehydratase.

21. The non-naturally occurring microbial organism of claim 1 , wherein said at least one exogenous nucleic acid is a heterologous nucleic acid.

22. The non-naturally occurring microbial organism of claim 1 , wherein said non-naturally occurring microbial organism is in a substantially anaerobic culture medium.

23. The non-naturally occurring microbial organism of claim 1 , wherein said microbial organism is a bacteria, a yeast, or a fungus.

24. The non-naturally occurring microbial organism of claim 23 , wherein said bacteria is Escherichia coli.

25. A method for producing crotyl alcohol comprising culturing the non-naturally occurring microbial organism of claim 1 under conditions and for a sufficient period of time to produce crotyl alcohol.

26. The method of claim 25 , wherein said non-naturally occurring microbial organism is in a substantially anaerobic culture medium.

27. The method of claim 25 , wherein said method further comprises separating the butadiene from other components in the culture.

28. The method of claim 27 , wherein the separating comprises extraction, continuous liquid-liquid extraction, pervaporation, membrane filtration, membrane separation, reverse osmosis, distillation, centrifugation, extractive filtration, ion exchange chromatography, absorption chromatography, or ultrafiltration.

29. The non-naturally occurring microbial organism of claim 1 , wherein said microbial organism comprises two exogenous nucleic acids each encoding a metabolic pathway enzyme.

30. The non-naturally occurring microbial organism of claim 1 , wherein said microbial organism comprises three exogenous nucleic acids each encoding a metabolic pathway enzyme.

31. The non-naturally occurring microbial organism of claim 1 , wherein said microbial organism comprises four exogenous nucleic acids each encoding a metabolic pathway enzyme.

32. The non-naturally occurring microbial organism of claim 1 , wherein said microbial organism comprises five exogenous nucleic acids each encoding a metabolic pathway enzyme.

33. The non-naturally occurring microbial organism of claim 1 , wherein said microbial organism comprises six exogenous nucleic acids each encoding a metabolic pathway enzyme.

34. The non-naturally occurring microbial organism of claim 1 , wherein said microbial organism is a yeast.

35. The non-naturally occurring microbial organism of claim 1 , wherein said microbial organism is a fungus.

36. The non-naturally occurring microbial organism of claim 34 , wherein said yeast is Saccharomyces cerevisiae.

Assignments (3)
SECURITY INTEREST Recorded Feb 10, 2026
From: GENOMATICA, INC.
To: AGAIN BIO APS
Reel/Frame 074708/0001 →
SECURITY INTEREST Recorded Dec 9, 2025
From: GENOMATICA, INC.
To: NOVO HOLDINGS A/S, AS COLLATERAL AGENT
Reel/Frame 073915/0027 →
SECURITY INTEREST Recorded Jun 2, 2025
From: GENOMATICA, INC.
To: OXFORD FINANCE LLC
Reel/Frame 071471/0770 →